Papel de bupropión en el tratamiento de la depresión resistente. Manejo de bupropión en combinación

García-Parés, Gemma; Pérez-Blanco, Josefina; Sánchez-Pérez, Manel; Roncero, Carlos; Fora, Facund; Galvez Ortiz, Verónica; Cardoner-Álvarez, Narcís; Crespo-Blanco, José M; Navarro-Odriozola, Víctor.
Actas esp. psiquiatr ; 39(supl.2): 8-13, oct. 2011. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-97717

Documentos relacionados

  1. Augmentation With Aripiprazole or Bupropion, or a Switch to Nortriptyline, Effective for Treatment-Resistant Depression in Older Adults.
  2. Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM): Study Design and Treatment Characteristics of the First 396 Participants Randomized.
  3. Efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression or major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
  4. Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data.
  5. A revisionist model for treatment-resistant and difficult-to-treat depression.
  6. Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depression.
  7. Clinicians' Views on Treatment-Resistant Depression: 2016 Survey Reports.
  8. Depression - Advanced Treatments for Treatment-Resistant Depression.
  9. Hyponatraemia and confusion in a 70-year-old female when bupropion was added to dothiepin and escitalopram.
  10. Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence.